St. Jude Research
@stjuderesearch.bsky.social
730 followers 40 following 330 posts
St. Jude Children's Research Hospital: a leader in research and treatment of pediatric cancer and childhood diseases.
Posts Media Videos Starter Packs
stjuderesearch.bsky.social
This discovery clarifies how disruptions in stress granule regulation can contribute to conditions such as multisystem proteinopathy, amyotrophic lateral sclerosis and frontotemporal dementia, highlighting potential therapeutic targets.
stjuderesearch.bsky.social
This discovery clarifies how disruptions in stress granule regulation can contribute to conditions such as multisystem proteinopathy, amyotrophic lateral sclerosis and frontotemporal dementia, highlighting potential therapeutic targets
stjuderesearch.bsky.social
St. Jude is advancing therapies such as immunotherapy and precision medicine while expanding global access to care through collaborations with WHO, UNICEF and others.
stjuderesearch.bsky.social
"To be named among the top children’s cancer hospitals every year since the rankings began is a reflection of our people—their brilliance, their heart and their unwavering commitment to our mission,” said James R. Downing, MD, president and CEO.
stjuderesearch.bsky.social
St. Jude Children’s Research Hospital has been ranked among the top 10
pediatric cancer hospitals by U.S. News & World Report for the 18th year in a row.

Read more: ow.ly/HNLN50X7PsR
stjuderesearch.bsky.social
Alongside wellness programs, growth opportunities and more, our new childcare center sets us apart in our support of our staff’s well-being. “The center was near full subscription not long after opening,” said Maria Megdal, EVP and chief administrative officer.
stjuderesearch.bsky.social
Proud to be ranked No. 2 on the @Forbes list of Best Employers for Healthcare Professionals! At St. Jude, we invest in our team so they can focus on our lifesaving mission.

ow.ly/HPal50X6mBj
stjuderesearch.bsky.social
The application deadline for the 2026 CCSS Ann C. Mertens Career Development Award has been extended through Monday, November 3.

This is a great opportunity for early-career investigators and trainees interested in childhood cancer survivorship research. Learn more: ow.ly/GOzN50WCMpP
stjuderesearch.bsky.social
Shape the future of childhood cancer survivorship with the 2026 CCSS Ann C. Mertens Career Development Award. This opportunity provides early-career investigators with the tools, resources and mentorship to advance survivorship research and improve outcomes.
Mostly blue graphic with text containing the announcement of the 2026 Career Development Award from the Childhood Cancer Survivor Study with an October 6, 2025 deadline.
stjuderesearch.bsky.social
“These methods are now being used by other labs to study important processes in the brain in ways that haven’t been done before,” said @lindsayschwarz.bsky.social, PhD. As technology continues to evolve, St. Jude researchers are lighting the way to new knowledge.
stjuderesearch.bsky.social
Innovations include self-healing fluorophores for more precise imaging, an intersectional genetic platform to label rare neuronal populations and the first visualization of cytonemes in mammalian tissue. All discoveries are driven by advances in fluorescence and microscopy.
stjuderesearch.bsky.social
St. Jude researchers are advancing science by harnessing light-based technologies to explore the molecular and cellular mechanisms underlying health and disease. ow.ly/3TEI50X4nsQ
A gloved hand adjusts a component inside a complex scientific instrument. Text on image reads "Scientific Report 2025" titled Lighting the Way to Knowledge, with the subtitle Translating Science Into Survival. The St. Jude logo appears in the top right corner.
stjuderesearch.bsky.social
This event showed the power of collaboration, sharing best practices, fostering new partnerships, & driving action for sickle cell disease and childhood cancer. The convening power of St. Jude brings leaders together to build lasting, resilient health systems for all children.
stjuderesearch.bsky.social
At #UNGA80, St. Jude & Uzbekistan co-hosted a landmark side event, united by Bente Mikkelsen’s leadership, 8 first ladies, WHO DG @DrTedros & ministers of health worldwide. Together, we’re advancing global health for children facing catastrophic diseases.
stjuderesearch.bsky.social
If successful, this technology could improve the accuracy of infection diagnosis, reduce unnecessary procedures and advance care for patients with sickle cell disease. Future trials will focus on its application in clinical settings.
stjuderesearch.bsky.social
“[18F]fluoromannitol’s ability to accumulate only in bacteria indicated it to be a sensitive bacterial imaging agent worthy of further investigation,” said Kiel Neumann, PhD.
stjuderesearch.bsky.social
A novel radiotracer, [18F]fluoromannitol, is now entering a first-in-human clinical trial at St. Jude. This PET/CT imaging agent could help clinicians distinguish between disease-related inflammation and bacterial infection in patients with sickle cell disease. ow.ly/PV9u50X3PJn
Two scientists in lab coats examining a wired device in a laboratory. Text on image reads: 'New radiotracer for infection detection enters first in-human clinical trial.'" The St. Jude child logo is above the text.
stjuderesearch.bsky.social
“Achieving exceptional status for the third consecutive time is a testament to the work of our faculty and staff members, and the impact this Center has on pediatric cancer research and treatment,” said Charles Roberts, MD, PhD.
stjuderesearch.bsky.social
We have received our third consecutive exceptional rating from the National Cancer Institute as a Comprehensive Cancer Center, the highest distinction awarded. St. Jude remains the only center of its kind devoted solely to children.

Learn more: ow.ly/GPA350X3P3X
stjuderesearch.bsky.social
“Achieving exceptional status for the third consecutive time is a testament to the work of our faculty and staff members, and the impact this Center has on pediatric cancer research and treatment,” said Charles Roberts, MD, PhD.
stjuderesearch.bsky.social
Unpasteurized H5N1-infected milk remains a health concern, but pre-existing immunity from seasonal flu provided full protection. Current food safety and vaccination practices are likely effective.
stjuderesearch.bsky.social
New study reveals pasteurized milk containing H5N1 influenza viral components poses minimal health risks and doesn’t alter influenza immunity. Regularly drinking contaminated pasteurized milk doesn’t increase flu susceptibility in model systems. ow.ly/stPC50X32eB
Person in a bright pink blazer standing in a hallway. Text overlay reads: Pasteurized milk with H5N1 viral components does not impact flu immunity. St. Jude Children's Research Hospital logo in the corner.
stjuderesearch.bsky.social
Aligning data on diagnosis is a priority supported by the Cancer Classifications for Kids portal from St. Jude Cloud. “Cancer type and subtype are probably the most fundamental lens through which we look at cancer, both in the clinic and the research setting,” said Michael Rusch.
stjuderesearch.bsky.social
The API enables researchers to query harmonized data across platforms, streamlining access and analysis. "The API catalogs and allows user exploration of pediatric cancer research data contained within the federated data ecosystem—institutions across the US," said Clay McLeod.